|Articles|January 1, 2003
FDA Brief
The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Achieving a new level of refractive precision: Surgical strategies
4
Global trial equity: How LMIC data is reshaping US ophthalmology research
5